This research report provides a comprehensive analysis of the Urology Drugs market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Urology Drugs market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Urology Drugs, challenges faced by the industry, and potential opportunities for market players.
The global Urology Drugs market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Urology Drugs market presents opportunities for various stakeholders, including Hospital, Clinic. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Urology Drugs market. Additionally, the growing consumer demand present avenues for market expansion.
The global Urology Drugs market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Key Features:
The research report on the Urology Drugs market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Urology Drugs market.
Market Overview: The report provides a comprehensive overview of the Urology Drugs market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., ? (alpha) Blockers, 5 ?-reductase Inhibitors), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Urology Drugs market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Urology Drugs market's trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Urology Drugs market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Urology Drugs market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Urology Drugs market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Urology Drugs market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Urology Drugs, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Urology Drugs market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Urology Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
? (alpha) Blockers
5 ?-reductase Inhibitors
Market segment by Application
Hospital
Clinic
Others
Global Urology Drugs Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Astellas
Endo
GP Pharm
Tolmar
Outline of Major Chapters:
Chapter 1: Introduces the definition of Urology Drugs, market overview.
Chapter 2: Global Urology Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Urology Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Urology Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Urology Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Urology Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Urology Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Urology Drugs Overall Market Size
2.1 Global Urology Drugs Market Size: 2023 VS 2030
2.2 Global Urology Drugs Revenue, Prospects & Forecasts: 2019-2030
2.3 Global Urology Drugs Sales: 2019-2030
3 Company Landscape
3.1 Top Urology Drugs Players in Global Market
3.2 Top Global Urology Drugs Companies Ranked by Revenue
3.3 Global Urology Drugs Revenue by Companies
3.4 Global Urology Drugs Sales by Companies
3.5 Global Urology Drugs Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 Urology Drugs Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers Urology Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Urology Drugs Players in Global Market
3.8.1 List of Global Tier 1 Urology Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Urology Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Urology Drugs Market Size Markets, 2023 & 2030
4.1.2 ? (alpha) Blockers
4.1.3 5 ?-reductase Inhibitors
4.2 By Type - Global Urology Drugs Revenue & Forecasts
4.2.1 By Type - Global Urology Drugs Revenue, 2019-2024
4.2.2 By Type - Global Urology Drugs Revenue, 2025-2030
4.2.3 By Type - Global Urology Drugs Revenue Market Share, 2019-2030
4.3 By Type - Global Urology Drugs Sales & Forecasts
4.3.1 By Type - Global Urology Drugs Sales, 2019-2024
4.3.2 By Type - Global Urology Drugs Sales, 2025-2030
4.3.3 By Type - Global Urology Drugs Sales Market Share, 2019-2030
4.4 By Type - Global Urology Drugs Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Urology Drugs Market Size, 2023 & 2030
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Others
5.2 By Application - Global Urology Drugs Revenue & Forecasts
5.2.1 By Application - Global Urology Drugs Revenue, 2019-2024
5.2.2 By Application - Global Urology Drugs Revenue, 2025-2030
5.2.3 By Application - Global Urology Drugs Revenue Market Share, 2019-2030
5.3 By Application - Global Urology Drugs Sales & Forecasts
5.3.1 By Application - Global Urology Drugs Sales, 2019-2024
5.3.2 By Application - Global Urology Drugs Sales, 2025-2030
5.3.3 By Application - Global Urology Drugs Sales Market Share, 2019-2030
5.4 By Application - Global Urology Drugs Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
6.1 By Region - Global Urology Drugs Market Size, 2023 & 2030
6.2 By Region - Global Urology Drugs Revenue & Forecasts
6.2.1 By Region - Global Urology Drugs Revenue, 2019-2024
6.2.2 By Region - Global Urology Drugs Revenue, 2025-2030
6.2.3 By Region - Global Urology Drugs Revenue Market Share, 2019-2030
6.3 By Region - Global Urology Drugs Sales & Forecasts
6.3.1 By Region - Global Urology Drugs Sales, 2019-2024
6.3.2 By Region - Global Urology Drugs Sales, 2025-2030
6.3.3 By Region - Global Urology Drugs Sales Market Share, 2019-2030
6.4 North America
6.4.1 By Country - North America Urology Drugs Revenue, 2019-2030
6.4.2 By Country - North America Urology Drugs Sales, 2019-2030
6.4.3 US Urology Drugs Market Size, 2019-2030
6.4.4 Canada Urology Drugs Market Size, 2019-2030
6.4.5 Mexico Urology Drugs Market Size, 2019-2030
6.5 Europe
6.5.1 By Country - Europe Urology Drugs Revenue, 2019-2030
6.5.2 By Country - Europe Urology Drugs Sales, 2019-2030
6.5.3 Germany Urology Drugs Market Size, 2019-2030
6.5.4 France Urology Drugs Market Size, 2019-2030
6.5.5 U.K. Urology Drugs Market Size, 2019-2030
6.5.6 Italy Urology Drugs Market Size, 2019-2030
6.5.7 Russia Urology Drugs Market Size, 2019-2030
6.5.8 Nordic Countries Urology Drugs Market Size, 2019-2030
6.5.9 Benelux Urology Drugs Market Size, 2019-2030
6.6 Asia
6.6.1 By Region - Asia Urology Drugs Revenue, 2019-2030
6.6.2 By Region - Asia Urology Drugs Sales, 2019-2030
6.6.3 China Urology Drugs Market Size, 2019-2030
6.6.4 Japan Urology Drugs Market Size, 2019-2030
6.6.5 South Korea Urology Drugs Market Size, 2019-2030
6.6.6 Southeast Asia Urology Drugs Market Size, 2019-2030
6.6.7 India Urology Drugs Market Size, 2019-2030
6.7 South America
6.7.1 By Country - South America Urology Drugs Revenue, 2019-2030
6.7.2 By Country - South America Urology Drugs Sales, 2019-2030
6.7.3 Brazil Urology Drugs Market Size, 2019-2030
6.7.4 Argentina Urology Drugs Market Size, 2019-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Urology Drugs Revenue, 2019-2030
6.8.2 By Country - Middle East & Africa Urology Drugs Sales, 2019-2030
6.8.3 Turkey Urology Drugs Market Size, 2019-2030
6.8.4 Israel Urology Drugs Market Size, 2019-2030
6.8.5 Saudi Arabia Urology Drugs Market Size, 2019-2030
6.8.6 UAE Urology Drugs Market Size, 2019-2030
7 Manufacturers & Brands Profiles
7.1 Astellas
7.1.1 Astellas Company Summary
7.1.2 Astellas Business Overview
7.1.3 Astellas Urology Drugs Major Product Offerings
7.1.4 Astellas Urology Drugs Sales and Revenue in Global (2019-2024)
7.1.5 Astellas Key News & Latest Developments
7.2 Endo
7.2.1 Endo Company Summary
7.2.2 Endo Business Overview
7.2.3 Endo Urology Drugs Major Product Offerings
7.2.4 Endo Urology Drugs Sales and Revenue in Global (2019-2024)
7.2.5 Endo Key News & Latest Developments
7.3 GP Pharm
7.3.1 GP Pharm Company Summary
7.3.2 GP Pharm Business Overview
7.3.3 GP Pharm Urology Drugs Major Product Offerings
7.3.4 GP Pharm Urology Drugs Sales and Revenue in Global (2019-2024)
7.3.5 GP Pharm Key News & Latest Developments
7.4 Tolmar
7.4.1 Tolmar Company Summary
7.4.2 Tolmar Business Overview
7.4.3 Tolmar Urology Drugs Major Product Offerings
7.4.4 Tolmar Urology Drugs Sales and Revenue in Global (2019-2024)
7.4.5 Tolmar Key News & Latest Developments
8 Global Urology Drugs Production Capacity, Analysis
8.1 Global Urology Drugs Production Capacity, 2019-2030
8.2 Urology Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Urology Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Urology Drugs Supply Chain Analysis
10.1 Urology Drugs Industry Value Chain
10.2 Urology Drugs Upstream Market
10.3 Urology Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Urology Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Urology Drugs in Global Market
Table 2. Top Urology Drugs Players in Global Market, Ranking by Revenue (2023)
Table 3. Global Urology Drugs Revenue by Companies, (US$, Mn), 2019-2024
Table 4. Global Urology Drugs Revenue Share by Companies, 2019-2024
Table 5. Global Urology Drugs Sales by Companies, (MT), 2019-2024
Table 6. Global Urology Drugs Sales Share by Companies, 2019-2024
Table 7. Key Manufacturers Urology Drugs Price (2019-2024) & (USD/Kg)
Table 8. Global Manufacturers Urology Drugs Product Type
Table 9. List of Global Tier 1 Urology Drugs Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Urology Drugs Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Urology Drugs Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Global Urology Drugs Revenue (US$, Mn), 2019-2024
Table 13. By Type - Global Urology Drugs Revenue (US$, Mn), 2025-2030
Table 14. By Type - Global Urology Drugs Sales (MT), 2019-2024
Table 15. By Type - Global Urology Drugs Sales (MT), 2025-2030
Table 16. By Application ? Global Urology Drugs Revenue, (US$, Mn), 2023 & 2030
Table 17. By Application - Global Urology Drugs Revenue (US$, Mn), 2019-2024
Table 18. By Application - Global Urology Drugs Revenue (US$, Mn), 2025-2030
Table 19. By Application - Global Urology Drugs Sales (MT), 2019-2024
Table 20. By Application - Global Urology Drugs Sales (MT), 2025-2030
Table 21. By Region ? Global Urology Drugs Revenue, (US$, Mn), 2023 VS 2030
Table 22. By Region - Global Urology Drugs Revenue (US$, Mn), 2019-2024
Table 23. By Region - Global Urology Drugs Revenue (US$, Mn), 2025-2030
Table 24. By Region - Global Urology Drugs Sales (MT), 2019-2024
Table 25. By Region - Global Urology Drugs Sales (MT), 2025-2030
Table 26. By Country - North America Urology Drugs Revenue, (US$, Mn), 2019-2024
Table 27. By Country - North America Urology Drugs Revenue, (US$, Mn), 2025-2030
Table 28. By Country - North America Urology Drugs Sales, (MT), 2019-2024
Table 29. By Country - North America Urology Drugs Sales, (MT), 2025-2030
Table 30. By Country - Europe Urology Drugs Revenue, (US$, Mn), 2019-2024
Table 31. By Country - Europe Urology Drugs Revenue, (US$, Mn), 2025-2030
Table 32. By Country - Europe Urology Drugs Sales, (MT), 2019-2024
Table 33. By Country - Europe Urology Drugs Sales, (MT), 2025-2030
Table 34. By Region - Asia Urology Drugs Revenue, (US$, Mn), 2019-2024
Table 35. By Region - Asia Urology Drugs Revenue, (US$, Mn), 2025-2030
Table 36. By Region - Asia Urology Drugs Sales, (MT), 2019-2024
Table 37. By Region - Asia Urology Drugs Sales, (MT), 2025-2030
Table 38. By Country - South America Urology Drugs Revenue, (US$, Mn), 2019-2024
Table 39. By Country - South America Urology Drugs Revenue, (US$, Mn), 2025-2030
Table 40. By Country - South America Urology Drugs Sales, (MT), 2019-2024
Table 41. By Country - South America Urology Drugs Sales, (MT), 2025-2030
Table 42. By Country - Middle East & Africa Urology Drugs Revenue, (US$, Mn), 2019-2024
Table 43. By Country - Middle East & Africa Urology Drugs Revenue, (US$, Mn), 2025-2030
Table 44. By Country - Middle East & Africa Urology Drugs Sales, (MT), 2019-2024
Table 45. By Country - Middle East & Africa Urology Drugs Sales, (MT), 2025-2030
Table 46. Astellas Company Summary
Table 47. Astellas Urology Drugs Product Offerings
Table 48. Astellas Urology Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2019-2024)
Table 49. Astellas Key News & Latest Developments
Table 50. Endo Company Summary
Table 51. Endo Urology Drugs Product Offerings
Table 52. Endo Urology Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2019-2024)
Table 53. Endo Key News & Latest Developments
Table 54. GP Pharm Company Summary
Table 55. GP Pharm Urology Drugs Product Offerings
Table 56. GP Pharm Urology Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2019-2024)
Table 57. GP Pharm Key News & Latest Developments
Table 58. Tolmar Company Summary
Table 59. Tolmar Urology Drugs Product Offerings
Table 60. Tolmar Urology Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2019-2024)
Table 61. Tolmar Key News & Latest Developments
Table 62. Urology Drugs Production Capacity (MT) of Key Manufacturers in Global Market, 2022-2024 (MT)
Table 63. Global Urology Drugs Capacity Market Share of Key Manufacturers, 2022-2024
Table 64. Global Urology Drugs Production by Region, 2019-2024 (MT)
Table 65. Global Urology Drugs Production by Region, 2025-2030 (MT)
Table 66. Urology Drugs Market Opportunities & Trends in Global Market
Table 67. Urology Drugs Market Drivers in Global Market
Table 68. Urology Drugs Market Restraints in Global Market
Table 69. Urology Drugs Raw Materials
Table 70. Urology Drugs Raw Materials Suppliers in Global Market
Table 71. Typical Urology Drugs Downstream
Table 72. Urology Drugs Downstream Clients in Global Market
Table 73. Urology Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Urology Drugs Segment by Type in 2023
Figure 2. Urology Drugs Segment by Application in 2023
Figure 3. Global Urology Drugs Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Urology Drugs Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Urology Drugs Revenue, 2019-2030 (US$, Mn)
Figure 7. Urology Drugs Sales in Global Market: 2019-2030 (MT)
Figure 8. The Top 3 and 5 Players Market Share by Urology Drugs Revenue in 2023
Figure 9. By Type - Global Urology Drugs Revenue, (US$, Mn), 2023 & 2030
Figure 10. By Type - Global Urology Drugs Revenue Market Share, 2019-2030
Figure 11. By Type - Global Urology Drugs Sales Market Share, 2019-2030
Figure 12. By Type - Global Urology Drugs Price (USD/Kg), 2019-2030
Figure 13. By Application - Global Urology Drugs Revenue, (US$, Mn), 2023 & 2030
Figure 14. By Application - Global Urology Drugs Revenue Market Share, 2019-2030
Figure 15. By Application - Global Urology Drugs Sales Market Share, 2019-2030
Figure 16. By Application - Global Urology Drugs Price (USD/Kg), 2019-2030
Figure 17. By Region - Global Urology Drugs Revenue, (US$, Mn), 2023 & 2030
Figure 18. By Region - Global Urology Drugs Revenue Market Share, 2019 VS 2023 VS 2030
Figure 19. By Region - Global Urology Drugs Revenue Market Share, 2019-2030
Figure 20. By Region - Global Urology Drugs Sales Market Share, 2019-2030
Figure 21. By Country - North America Urology Drugs Revenue Market Share, 2019-2030
Figure 22. By Country - North America Urology Drugs Sales Market Share, 2019-2030
Figure 23. US Urology Drugs Revenue, (US$, Mn), 2019-2030
Figure 24. Canada Urology Drugs Revenue, (US$, Mn), 2019-2030
Figure 25. Mexico Urology Drugs Revenue, (US$, Mn), 2019-2030
Figure 26. By Country - Europe Urology Drugs Revenue Market Share, 2019-2030
Figure 27. By Country - Europe Urology Drugs Sales Market Share, 2019-2030
Figure 28. Germany Urology Drugs Revenue, (US$, Mn), 2019-2030
Figure 29. France Urology Drugs Revenue, (US$, Mn), 2019-2030
Figure 30. U.K. Urology Drugs Revenue, (US$, Mn), 2019-2030
Figure 31. Italy Urology Drugs Revenue, (US$, Mn), 2019-2030
Figure 32. Russia Urology Drugs Revenue, (US$, Mn), 2019-2030
Figure 33. Nordic Countries Urology Drugs Revenue, (US$, Mn), 2019-2030
Figure 34. Benelux Urology Drugs Revenue, (US$, Mn), 2019-2030
Figure 35. By Region - Asia Urology Drugs Revenue Market Share, 2019-2030
Figure 36. By Region - Asia Urology Drugs Sales Market Share, 2019-2030
Figure 37. China Urology Drugs Revenue, (US$, Mn), 2019-2030
Figure 38. Japan Urology Drugs Revenue, (US$, Mn), 2019-2030
Figure 39. South Korea Urology Drugs Revenue, (US$, Mn), 2019-2030
Figure 40. Southeast Asia Urology Drugs Revenue, (US$, Mn), 2019-2030
Figure 41. India Urology Drugs Revenue, (US$, Mn), 2019-2030
Figure 42. By Country - South America Urology Drugs Revenue Market Share, 2019-2030
Figure 43. By Country - South America Urology Drugs Sales Market Share, 2019-2030
Figure 44. Brazil Urology Drugs Revenue, (US$, Mn), 2019-2030
Figure 45. Argentina Urology Drugs Revenue, (US$, Mn), 2019-2030
Figure 46. By Country - Middle East & Africa Urology Drugs Revenue Market Share, 2019-2030
Figure 47. By Country - Middle East & Africa Urology Drugs Sales Market Share, 2019-2030
Figure 48. Turkey Urology Drugs Revenue, (US$, Mn), 2019-2030
Figure 49. Israel Urology Drugs Revenue, (US$, Mn), 2019-2030
Figure 50. Saudi Arabia Urology Drugs Revenue, (US$, Mn), 2019-2030
Figure 51. UAE Urology Drugs Revenue, (US$, Mn), 2019-2030
Figure 52. Global Urology Drugs Production Capacity (MT), 2019-2030
Figure 53. The Percentage of Production Urology Drugs by Region, 2023 VS 2030
Figure 54. Urology Drugs Industry Value Chain
Figure 55. Marketing Channels
